Christin Tse

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor

Christin Tse, Alexander R. Shoemaker, Jessica Adickes et al. · Cancer Research · 2008 · 2K citations · Full text

Medicine, Oncology, Pharmacology +16

Disruption of Higher-Order Folding by Core Histone Acetylation Dramatically Enhances Transcription of Nucleosomal Arrays by RNA Polymerase III

Christin Tse, Takashi Sera, Alan P. Wolffe et al. · Molecular and Cellular Biology · 1998 · 571 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

H Zhang, J Chen, Sajid Khan Tahir et al. · Cell Death and Disease · 2015 · 429 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Bcl-2 family proteins are essential for platelet survival

H Zhang, Paul Nimmer, Stephen K Tahir et al. · Cell Death and Differentiation · 2007 · 426 citations

Life Sciences, Hematology, Molecular Biology +14

Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737

Stephen K. Tahir, Xiufen Yang, Mark G. Anderson et al. · Cancer Research · 2007 · 302 citations

Medicine, Oncology, Pharmacology +13